再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09688 再鼎医药

未开盘 10-08 16:08:49

26.100

-0.200

-0.76%

最高26.360	最低25.480	成交量300.58万
今开26.300	昨收26.300	日振幅3.35%
总市值291.80亿	流通市值291.80亿	总股本11.18亿
成交额7,812万	换手率0.27%	流通股本11.18亿
市净率4.74	ROE-28.41%	每股收益-2.02
52周最高35.500	52周最低17.740	市盈率-12.91
股息0.00	股息收益率0.00	ROA-14.35%

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09688","market":"HK","secType":"STK","nameCN":"再鼎医药","latestPrice":26.1,"timestamp":1759910929006,"preClose":26.3,"halted":0,"volume":3005833,"delay":0,"floatShares":1118000000,"shares":1118000000,"eps":-2.0219834093349722,"marketStatus":"未开盘","change":-0.2,"latestTime":"10-08 16:08:49","open":26.3,"high":26.36,"low":25.48,"amount":78119999,"amplitude":0.03346,"askPrice":26.1,"askSize":118900,"bidPrice":26.08,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-1.581933917482452,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1759973400000},"marketStatusCode":0,"adr":0,"listingDate":1601222400000,"exchange":"SEHK","adjPreClose":26.3,"openAndCloseTimeList":[[1759887000000,1759896000000],[1759899600000,1759910400000]],"volumeRatio":0.47082671708517804,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09688","defaultTab":"news","newsList":[{"id":"2572519244","title":"再鼎医药(09688)授出购股权和受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2572519244","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572519244?lang=zh_cn&edition=full","pubTime":"2025-10-02 19:12","pubTimestamp":1759403553,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)发布公告，于2025年10月1日(美国东部时间)，公司根据2024年股权激励计划向1名承授人授出可认购合共2.5万股美国存托股份的购股权并向7名承授人涉及合共3.22万股美国存托股份的受限制股份单位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1351960.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4526","BK4588","09688","BK4531","LU2488822045.USD","BK4548","BK1588","BK4139","BK1574","BK4585","ZLAB","BK1161"],"gpt_icon":0},{"id":"2572512832","title":"每日卖空追踪 | 再鼎医药 10月02日卖空量成交21.02万股，卖空比例为5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572512832","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572512832?lang=zh_cn&edition=full","pubTime":"2025-10-02 16:30","pubTimestamp":1759393840,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间10月02日，涨1.42%，卖空量成交21.02万股，较上一交易日减少92.21%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100216345694b84d04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100216345694b84d04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","BK1161","BK1574","LU2488822045.USD","09688"],"gpt_icon":0},{"id":"2572128535","title":"再鼎医药10月02日获主力加仓404.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572128535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572128535?lang=zh_cn&edition=full","pubTime":"2025-10-02 16:16","pubTimestamp":1759392960,"startTime":"0","endTime":"0","summary":"10月02日, 再鼎医药股价涨1.42%，报收27.06元，成交金额9586.3万元，换手率0.32%，振幅2.85%，量比0.38。再鼎医药今日主力资金净流入404.5万元，连续4日净流入，上一交易日主力净流入5575.5万元。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为53.85%，平均涨幅为3.36%。该股近5个交易日上涨6.18%，主力资金累计净流入6464.3万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入3.7亿元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251002162141a45112f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251002162141a45112f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09688","LU2488822045.USD","BK1161","BK1588"],"gpt_icon":0},{"id":"2572951285","title":"中金医药10月组合：看好创新药及产业链 期待商保突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2572951285","media":"中金公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572951285?lang=zh_cn&edition=full","pubTime":"2025-10-02 00:00","pubTimestamp":1759334400,"startTime":"0","endTime":"0","summary":"行业动态行业近况过去一个月，医药板块指数下跌1.7%，上证综指上涨0.6%，深证成指上涨6.5%，创业板指上涨12.0%。评论看好创新药长期产业发展趋势。我们认为进入2.0 时代的创新药产业已经逐步完成质的提升。投融资预期改善，有望带来创新产业链订单繁荣。受益于年初以来以港股18A 为代表的创新药行业繁荣，目前一二级市场投融资一改过去3-4 年的颓势，二季度开始出现较为明显的反转。风险研发失败，商业化不及预期，集采降价超预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251002201635971d2f8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251002201635971d2f8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09926","BK1161","BK1588","09939","BK1515","01177","01276","LU2488822045.USD","09688","06978","BK1574"],"gpt_icon":0},{"id":"2571326908","title":"美股异动 | 再鼎医药(ZLAB.US)涨逾4%  机构：药品关税对产业链影响有限","url":"https://stock-news.laohu8.com/highlight/detail?id=2571326908","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571326908?lang=zh_cn&edition=full","pubTime":"2025-09-30 22:12","pubTimestamp":1759241543,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，再鼎医药涨逾4%，报34.43美元。消息面上，特朗普近期宣布，10月起对所有品牌/专利药征收100%关税，除非该制造商正在美国境内兴建生产设施。交银国际认为，这对中国创新药产业链影响有限，无需过度担忧。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1351558.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4531","BK4588","LU2488822045.USD","BK4139","BK1588","BK4548","BK1161","ZLAB","09688","BK4585","BK1574","BK4526"],"gpt_icon":0},{"id":"1198082253","title":"港股异动 | 创新药概念股上涨，再鼎医药、诺诚健华涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198082253","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198082253?lang=zh_cn&edition=full","pubTime":"2025-09-30 11:07","pubTimestamp":1759201630,"startTime":"0","endTime":"0","summary":"9月30日，港股创新药概念股盘中上涨，$再鼎医药(09688)$、$诺诚健华(09969)$涨超7%，$药明康德(02359)$、$康方生物(09926)$涨超5%，$歌礼制药-B(01672)$涨超4%，$金斯瑞生物科技(01548)$涨超3%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359","LU2488822045.USD","09969","BK1161","BK4588","BK0239","BK4139","BK4614","09688","BK4585","BK4548","BK4526","BK4531","BK1588","BK1574"],"gpt_icon":0},{"id":"2571395433","title":"港股生物医药板块活跃，再鼎医药涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571395433","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571395433?lang=zh_cn&edition=full","pubTime":"2025-09-30 10:02","pubTimestamp":1759197721,"startTime":"0","endTime":"0","summary":"每经AI快讯，9月30日，港股生物医药板块活跃，再鼎医药涨超5%，药明康德、荣昌生物、诺诚健华等个股跟涨。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202509303527247688.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509303527247688.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4139","BK4614","BK1588","HSCEI","YANG","BK1574","BK4588","BK1161","BK4526","BK4548","BK4585","HSTECH","LU2488822045.USD","BK4531","09688","ZLAB"],"gpt_icon":0},{"id":"2571362678","title":"每日卖空追踪 | 再鼎医药 09月29日卖空量成交22.74万股，卖空比例为2.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571362678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571362678?lang=zh_cn&edition=full","pubTime":"2025-09-29 16:30","pubTimestamp":1759134643,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间09月29日，涨2.38%，卖空量成交22.74万股，较上一交易日减少83.26%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929163539a44be540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929163539a44be540&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","09688","LU2488822045.USD","BK1161","BK1574"],"gpt_icon":0},{"id":"2571930362","title":"再鼎医药09月29日获主力加仓196.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2571930362","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571930362?lang=zh_cn&edition=full","pubTime":"2025-09-29 16:15","pubTimestamp":1759133730,"startTime":"0","endTime":"0","summary":"09月29日, 再鼎医药股价涨2.38%，报收24.90元，成交金额2.0亿元，换手率0.72%，振幅2.30%，量比1.13。再鼎医药今日主力资金净流入196.4万元，上一交易日主力净流入619.4万元。该股近5个交易日下跌2.60%，主力资金累计净流出35.6万元；近20日主力资金累计净流入3.3亿元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929161734954bdcd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929161734954bdcd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1588","BK1161","09688","BK1574"],"gpt_icon":0},{"id":"2570882864","title":"每日卖空追踪 | 再鼎医药 09月26日卖空量成交60.39万股，卖空比例为6.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570882864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570882864?lang=zh_cn&edition=full","pubTime":"2025-09-26 16:30","pubTimestamp":1758875441,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间09月26日，跌3.49%，卖空量成交60.39万股，较上一交易日减少33.9%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926163533a69f9cf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926163533a69f9cf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1588","BK1574","09688","BK1161"],"gpt_icon":0},{"id":"2570802615","title":"鬼故事不一定能落地，但投资者的逻辑也应该慢慢变了","url":"https://stock-news.laohu8.com/highlight/detail?id=2570802615","media":"医曜","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570802615?lang=zh_cn&edition=full","pubTime":"2025-09-26 07:28","pubTimestamp":1758842910,"startTime":"0","endTime":"0","summary":"创新药的鬼故事不一定能落地，但投资者却应该提前做好医药投资逻辑切换的准备。也就是说，虽然BD依然可以给药企带来诸多益处，但终有一天投资者会不再以BD作为交易决策的核心逻辑。“BD为王”的逻辑注定会逐渐淡化，并且在投资者的争议之中找到新的投资主线。所以投资者对于BD的关注应该适当降温，并做好达成新共识的准备。从研发预期，向商业化成绩落地，这将是中国创新药投资的大趋势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926073037a4446495&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926073037a4446495&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","LU0359201612.USD","01801","LEGN","01276","02096","01952","BK1161","06618","BK1574","02269","LU2543165471.USD","06978","09688","LU1023057109.AUD","01877","09995","LU0359201885.HKD","LU0359202008.SGD","BK1191","02142","06855"],"gpt_icon":0},{"id":"2570009048","title":"再鼎医药09月25日遭主力抛售331.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570009048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570009048?lang=zh_cn&edition=full","pubTime":"2025-09-25 16:15","pubTimestamp":1758788141,"startTime":"0","endTime":"0","summary":"09月25日, 再鼎医药股价跌0.24%，报收25.20元，成交金额1.8亿元，换手率0.64%，振幅2.22%，量比0.84。再鼎医药今日主力资金净流出331.4万元，连续5日净流出，上一交易日主力净流出14.3万元。该股近5个交易日下跌1.94%，主力资金累计净流出1980.5万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入3.2亿元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509251627379544472a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509251627379544472a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1161","LU2488822045.USD","BK1574","BK1588"],"gpt_icon":0},{"id":"2569613083","title":"每日卖空追踪 | 再鼎医药 09月24日卖空量成交28.95万股，卖空比例为4.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569613083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569613083?lang=zh_cn&edition=full","pubTime":"2025-09-24 16:30","pubTimestamp":1758702637,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间09月24日，跌0.08%，卖空量成交28.95万股，较上一交易日减少65.8%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924172040a440bbb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924172040a440bbb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09688","LU2488822045.USD","BK1161","BK1588"],"gpt_icon":0},{"id":"2569612083","title":"再鼎医药09月24日遭主力抛售14.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569612083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569612083?lang=zh_cn&edition=full","pubTime":"2025-09-24 16:15","pubTimestamp":1758701705,"startTime":"0","endTime":"0","summary":"09月24日, 再鼎医药股价跌0.08%，报收25.26元，成交金额1.7亿元，换手率0.60%，振幅2.14%，量比0.71。再鼎医药今日主力资金净流出14.3万元，连续4日净流出，上一交易日主力净流出505.7万元。近一年数据显示，该股主力连续4日净流出后，次日下跌概率为75.00%，平均跌幅为4.07%。该股近5个交易日上涨0.08%，主力资金累计净流入66.4万元；近20日主力资金累计净流入3.3亿元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924165346a69ae5cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924165346a69ae5cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","BK1574","BK1161","09688","LU2488822045.USD"],"gpt_icon":0},{"id":"2569099557","title":"美联储10月降息概率高达92%，港股医药高位回落","url":"https://stock-news.laohu8.com/highlight/detail?id=2569099557","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569099557?lang=zh_cn&edition=full","pubTime":"2025-09-24 10:11","pubTimestamp":1758679917,"startTime":"0","endTime":"0","summary":"美联储于9月18日如期宣布降息25bp，为港股市场提供了较为宽松的流动性环境。但当前距离10月29日议息尚有35天，美联储相关官员的发言在短期内引起较大扰动。据CME FedWatch Tool数据，美联储10月降息25bp的概率为91.9%；12月降息25bp的概率为21.7%，降息50bp的概率为77%。从二级市场来看，聚焦港股市场创新药+CXO的恒生医药ETF连续调整，自阶段高点回落近6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092410141595415b18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"ea3b3b54e2aa42d2aadd6617f904fcb8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092410141595415b18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SDS","SPXU",".SPX","BK4534","MESmain","SH","BK4550","OEX","UPRO","BK4139","BK4559","BK4585","BK4588","OEF","AAPG","ESmain","09606","SPY","BK4504","SSO","IVV","BK4581","09688"],"gpt_icon":0},{"id":"2569095723","title":"申万宏源：首予再鼎医药(09688)“买入”评级 目标价35.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569095723","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569095723?lang=zh_cn&edition=full","pubTime":"2025-09-24 09:13","pubTimestamp":1758676413,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，申万宏源发布研报称，随着商业化产品的销售放量，以及本地化生产布局，再鼎医药预计将于2025年四季度实现non-GAAP经营利润。基于DCF模型，给予目标价35.2港元。目标价对应39%的上涨空间，看好公司的创新管线布局，首次覆盖给予买入评级。2024年艾加莫德国内销售额达到0.94亿美元，同比增长835%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1348740.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000166","09688","ZLAB"],"gpt_icon":0},{"id":"2569724299","title":"创新药2025H1业绩综述：看好盈利改善 估值突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2569724299","media":"浙商证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569724299?lang=zh_cn&edition=full","pubTime":"2025-09-24 00:00","pubTimestamp":1758643200,"startTime":"0","endTime":"0","summary":"21家样本创新药企业销售费用率和研发费用率2021-2025H1持续下降，这也驱动百济神州、信达生物等公司盈利预期改善。17家已商业化创新药企业2025H1产品销售收入达到566亿元，同比增长30%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092411114395417876&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092411114395417876&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09926","02196","01801","BK1161","06978","09969","09688"],"gpt_icon":0},{"id":"2569731352","title":"每日卖空追踪 | 再鼎医药 09月22日卖空量成交135.66万股，卖空比例为19.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569731352","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569731352?lang=zh_cn&edition=full","pubTime":"2025-09-22 16:30","pubTimestamp":1758529842,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间09月22日，跌0.08%，卖空量成交135.66万股，较上一交易日减少56.19%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922163541a72ef502&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922163541a72ef502&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09688","BK1588","BK1574","LU2488822045.USD"],"gpt_icon":0},{"id":"2569731337","title":"再鼎医药09月22日遭主力抛售124.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569731337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569731337?lang=zh_cn&edition=full","pubTime":"2025-09-22 16:15","pubTimestamp":1758528937,"startTime":"0","endTime":"0","summary":"09月22日, 再鼎医药股价跌0.08%，报收25.34元，成交金额1.8亿元，换手率0.62%，振幅2.60%，量比0.54。再鼎医药今日主力资金净流出124.8万元，上一交易日主力净流出1004.3万元。该股近5个交易日上涨1.28%，主力资金累计净流入2431.3万元；近20日主力资金累计净流入3.3亿元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922161901953d6255&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922161901953d6255&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","09688","BK1574","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2569927174","title":"交易激增 129%，艾伯维、强生、BMS 等重金下注，这一赛道要爆了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2569927174","media":"丁香园 Insight 数据库","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569927174?lang=zh_cn&edition=full","pubTime":"2025-09-22 07:45","pubTimestamp":1758498351,"startTime":"0","endTime":"0","summary":"强生、艾伯维、BMS 等持续加码尽管精神分裂症药物研发折戟声此起彼伏，甚至有制药巨头选择退场，但仍有众多药企通过收购和合作等方式，持续加码这一高风险赛道。全球精神分裂症患者超过 2400 万，一经确诊就需长期治疗。III 期临床结果显示，与安慰剂相比，KarXT 在PANSS 总分具有统计学意义和临床意义的降低，有效改善精神分裂症的阳性和阴性症状。目前，恩华药业已推动该药进入 II 期临床。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922075542a72dff3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922075542a72dff3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01513","09688","BK1191","03692","01477","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zailaboratory.com","stockEarnings":[{"period":"1week","weight":-0.0217},{"period":"1month","weight":0.0308},{"period":"3month","weight":-0.0404},{"period":"6month","weight":0.1757},{"period":"1year","weight":0.4032},{"period":"ytd","weight":0.2488}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0466},{"period":"3month","weight":0.1166},{"period":"6month","weight":0.2828},{"period":"1year","weight":0.2821},{"period":"ytd","weight":0.3375}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"再鼎医药有限公司是一家主要从事生物制药的控股公司。该公司致力于通过产品的发现、开发和商业化解决肿瘤、自身免疫疾病、感染性疾病和中枢神经系统疾病领域未被满足的医疗需求。该公司拥有从发现阶段到临床项目后期的一系列专利候选药物。其中包括“则乐”、“OPTUNE”、“擎乐”、“纽再乐”及“卫伟迦”等。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.013207},{"month":2,"riseRate":0.6,"avgChangeRate":0.053227},{"month":3,"riseRate":0.2,"avgChangeRate":-0.100669},{"month":4,"riseRate":0.6,"avgChangeRate":0.032813},{"month":5,"riseRate":0.4,"avgChangeRate":-0.024133},{"month":6,"riseRate":0.4,"avgChangeRate":-0.013792},{"month":7,"riseRate":0.8,"avgChangeRate":0.065752},{"month":8,"riseRate":0.6,"avgChangeRate":-0.021717},{"month":9,"riseRate":0.4,"avgChangeRate":-0.054178},{"month":10,"riseRate":0.5,"avgChangeRate":-0.013857},{"month":11,"riseRate":0.6,"avgChangeRate":0.099288},{"month":12,"riseRate":0.4,"avgChangeRate":-0.001944}],"exchange":"SEHK","name":"再鼎医药","nameEN":"ZAI LAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供再鼎医药(09688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"再鼎医药,09688,再鼎医药股票,再鼎医药股票老虎,再鼎医药股票老虎国际,再鼎医药行情,再鼎医药股票行情,再鼎医药股价,再鼎医药股市,再鼎医药股票价格,再鼎医药股票交易,再鼎医药股票购买,再鼎医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供再鼎医药(09688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}